Haemophilus influenzae type b conjugate vaccines

Update

S. A. Plotkin, R. S. Daum, G. S. Giebink, C. B. Hall, M. L. Lepow, E. K. Marcuse, G. H. McCracken, C. F. Phillips, Gwendolyn B Scott, H. T. Wright

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

On December 22, 1988, a second conjugate vaccine was licensed by the US Food and Drug Administration for the prevention of infections caused by H influenzae type b in children 18 months of age or older. This newly licensed vaccine is a conjugate of H influenzae type b capsular oligosaccharide and a nontoxic mutant diphtheria toxin protein molecule called CRM197. The official designation of this vaccine is 'Haemophilus b conjugate vaccine (diphtheria CRM197 protein conjugate)' and it is often referred to as HbOC.

Original languageEnglish
Pages (from-to)386-387
Number of pages2
JournalPediatrics
Volume84
Issue number2
StatePublished - Jan 1 1989
Externally publishedYes

Fingerprint

Haemophilus influenzae type b
Conjugate Vaccines
Human Influenza
Haemophilus Vaccines
Diphtheria Toxin
Diphtheria
United States Food and Drug Administration
Oligosaccharides
Proteins
Vaccines
Infection
CRM197 (non-toxic variant of diphtheria toxin)

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Plotkin, S. A., Daum, R. S., Giebink, G. S., Hall, C. B., Lepow, M. L., Marcuse, E. K., ... Wright, H. T. (1989). Haemophilus influenzae type b conjugate vaccines: Update. Pediatrics, 84(2), 386-387.

Haemophilus influenzae type b conjugate vaccines : Update. / Plotkin, S. A.; Daum, R. S.; Giebink, G. S.; Hall, C. B.; Lepow, M. L.; Marcuse, E. K.; McCracken, G. H.; Phillips, C. F.; Scott, Gwendolyn B; Wright, H. T.

In: Pediatrics, Vol. 84, No. 2, 01.01.1989, p. 386-387.

Research output: Contribution to journalArticle

Plotkin, SA, Daum, RS, Giebink, GS, Hall, CB, Lepow, ML, Marcuse, EK, McCracken, GH, Phillips, CF, Scott, GB & Wright, HT 1989, 'Haemophilus influenzae type b conjugate vaccines: Update', Pediatrics, vol. 84, no. 2, pp. 386-387.
Plotkin SA, Daum RS, Giebink GS, Hall CB, Lepow ML, Marcuse EK et al. Haemophilus influenzae type b conjugate vaccines: Update. Pediatrics. 1989 Jan 1;84(2):386-387.
Plotkin, S. A. ; Daum, R. S. ; Giebink, G. S. ; Hall, C. B. ; Lepow, M. L. ; Marcuse, E. K. ; McCracken, G. H. ; Phillips, C. F. ; Scott, Gwendolyn B ; Wright, H. T. / Haemophilus influenzae type b conjugate vaccines : Update. In: Pediatrics. 1989 ; Vol. 84, No. 2. pp. 386-387.
@article{d02211aa207f4476a002d93258864420,
title = "Haemophilus influenzae type b conjugate vaccines: Update",
abstract = "On December 22, 1988, a second conjugate vaccine was licensed by the US Food and Drug Administration for the prevention of infections caused by H influenzae type b in children 18 months of age or older. This newly licensed vaccine is a conjugate of H influenzae type b capsular oligosaccharide and a nontoxic mutant diphtheria toxin protein molecule called CRM197. The official designation of this vaccine is 'Haemophilus b conjugate vaccine (diphtheria CRM197 protein conjugate)' and it is often referred to as HbOC.",
author = "Plotkin, {S. A.} and Daum, {R. S.} and Giebink, {G. S.} and Hall, {C. B.} and Lepow, {M. L.} and Marcuse, {E. K.} and McCracken, {G. H.} and Phillips, {C. F.} and Scott, {Gwendolyn B} and Wright, {H. T.}",
year = "1989",
month = "1",
day = "1",
language = "English",
volume = "84",
pages = "386--387",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "2",

}

TY - JOUR

T1 - Haemophilus influenzae type b conjugate vaccines

T2 - Update

AU - Plotkin, S. A.

AU - Daum, R. S.

AU - Giebink, G. S.

AU - Hall, C. B.

AU - Lepow, M. L.

AU - Marcuse, E. K.

AU - McCracken, G. H.

AU - Phillips, C. F.

AU - Scott, Gwendolyn B

AU - Wright, H. T.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - On December 22, 1988, a second conjugate vaccine was licensed by the US Food and Drug Administration for the prevention of infections caused by H influenzae type b in children 18 months of age or older. This newly licensed vaccine is a conjugate of H influenzae type b capsular oligosaccharide and a nontoxic mutant diphtheria toxin protein molecule called CRM197. The official designation of this vaccine is 'Haemophilus b conjugate vaccine (diphtheria CRM197 protein conjugate)' and it is often referred to as HbOC.

AB - On December 22, 1988, a second conjugate vaccine was licensed by the US Food and Drug Administration for the prevention of infections caused by H influenzae type b in children 18 months of age or older. This newly licensed vaccine is a conjugate of H influenzae type b capsular oligosaccharide and a nontoxic mutant diphtheria toxin protein molecule called CRM197. The official designation of this vaccine is 'Haemophilus b conjugate vaccine (diphtheria CRM197 protein conjugate)' and it is often referred to as HbOC.

UR - http://www.scopus.com/inward/record.url?scp=0024325043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024325043&partnerID=8YFLogxK

M3 - Article

VL - 84

SP - 386

EP - 387

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 2

ER -